-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Underweight on Helmerich & Payne, Lowers Price Target to $20

Benzinga·05/16/2025 15:56:29
Listen to the news
Morgan Stanley analyst Daniel Kutz maintains Helmerich & Payne (NYSE:HP) with a Underweight and lowers the price target from $27 to $20.